Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2002 R43 PAR-01-105 BECKER, CHRISTOPHER SURROMED, INC. AFFINITY MASS TAGS FOR DIFFERENTIAL PHENOTYPING Complete
2006 R21 RFA-CA-06-003 MEYER, TOBIAS STANFORD UNIVERSITY DISSECTION OF THE MODULAR STRUCTURE OF CANCER SIGNALING SYSTEMS Complete
2009 R21 RFA-CA-08-006 LESSNICK, STEPHEN L. UNIVERSITY OF UTAH ANTIBODY-BASED DETECTION OF TRANSLOCATIONS IN PEDIATRIC CANCER Complete
2012 R21 RFA-CA-12-002 TAO, NONGJIAN ARIZONA STATE UNIVERSITY-TEMPE CAMPUS CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH THROUGHPUT STUDY OF SMALL MOLECULES Complete
2016 R21 RFA-CA-15-002 BURGETT, ANTHONY WG UNIVERSITY OF OKLAHOMA NORMAN MASS SPECTROMETRY DETECTION OF DRUGS IN SINGLE BLADDER CANCER CELLS FROM PATIENTS Complete
2000 R21 PAR-99-100 MAJUMDAR, ARUNAVA UNIVERSITY OF CALIFORNIA BERKELEY OPTOMECHANICAL CHIPS FOR MOLECULAR PROFILING OF CANCER Complete
2002 R21 PAR-99-102 CHODOSH, LEWIS A UNIVERSITY OF PENNSYLVANIA TEMPORAL ANALYSIS OF MAMMARY CARCINOGENESIS Complete
2005 R21 RFA-CA-05-003 GREEN, ROLAND D NIMBLEGEN SYSTEMS, INC. MAPPING REGULATORY PATHWAYS IN CANCERS Complete
2008 R21 RFA-CA-07-035 KEELY, PATRICIA J UNIVERSITY OF WISCONSIN-MADISON USING NEW OPTICAL TECHNIQUES TO STUDY CELL SIGNALING IN 3D MATRICES Complete
2011 R21 RFA-CA-10-005 ZEICHNER, STEVEN L CHILDREN'S RESEARCH INSTITUTE DEVELOPMENT OF AN IN VIVO SCREENING TECHNOLOGY FOR CANCER VACCINE IMMUNOGENS Complete
2015 R21 RFA-CA-14-005 MITRAGOTRI, SAMIR S UNIVERSITY OF CALIFORNIA SANTA BARBARA ASSESSING THE RISK OF UV-INDUCED SKIN CANCER VIA NON-INVASIVE EPIDERMAL SAMPLING Complete
1999 R43 PAR-98-066 WEAVER, DANIEL C GENOMICA CORPORATION ANALYZING GENE EXPRESSION FOR CANCER GENE DISCOVERY Complete
2001 R43 PAR-99-101 WANG, JIWU ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INNOVATIVE RNA PROFILING IN CANCER CELLS Complete
2004 R43 PAR-01-105 NIELSEN, ULRIK B. MERRIMACK PHARMACEUTICALS, INC. PRODUCTION OF ANTIBODIES SUITABLE FOR MICROARRAYS Complete
2007 R33 RFA-CA-07-001 LIU, EDISON TAK-BUN GENOME INSTITUTE OF SINGAPORE PAIR-END-DITAG TECHNOLOGIES FOR THE COMPLETE ANNOTATION OF FUSION GENES Complete
2010 R21 RFA-CA-09-008 LIU, GUODONG NORTH DAKOTA STATE UNIVERSITY DEVELOPMENT OF A HAND-HELD CANCER BIOMARKER MONITOR Complete
2014 R33 RFA-CA-13-002 ROBINSON, WILLIAM H STANFORD UNIVERSITY LARGE-SCALE CHARACTERIZATION OF ANTI-CANCER ANTIBODY RESPONSES IN LUNG ADENOCARCI Complete
2001 R33 PAR-98-067 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED MINIMAL RESIDUAL DISEASE QUANTIFICATION Complete
2003 R41 PAR-01-105 SANTANGELO, PHILIP J VIVONETICS, INC. IN VIVO GENE EXPRESSION IMAGING FOR CANCER ANALYSIS Complete
2007 R21 RFA-CA-07-001 BIEBERICH, CHARLES J. UNIVERSITY OF MARYLAND BALT CO CAMPUS AN INNOVATIVE APPROACH FOR PROFILING PROTEIN KINASE SUBSTRATES Complete
2009 R33 RFA-CA-08-008 SHI, HUIDONG GEORGIA REGENTS UNIVERSITY APPLICATION OF 454 SEQUENCING TO CANCER EPIGENOMICS Complete
2013 R33 RFA-CA-12-003 BAILEY, RYAN C UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN MESO-PLEX MIRNA AND PROTEIN PROFILING FOR CANCER DIAGNOSTICS USING CHIP-INTEGRATE Complete
2016 R43 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2000 R43 PAR-99-101 BUTT, TAUSEEF R. LIFESENSORS, INC. LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER Complete
2002 R43 PAR-01-105 STRAUME, TORE GENMETRIX, LLC ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES Complete
2006 R21 RFA-CA-06-003 FERRARI, MAURO UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON NANOPARTICLES FOR HARVESTING AND TARGETING ANGIOGENIC PROTEINS Complete
2009 R21 RFA-CA-08-006 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST TECHNOLOGY FOR SENSITIVE AND RELIABLE MUTATIONAL PROFILING IN PANCREATIC CANCER Complete
2012 R21 RFA-CA-12-002 CARTEGNI, LUCA SLOAN-KETTERING INST CAN RESEARCH CONTROLLED PREMATURE TERMINATION OF TRANSLATION TO GENERATE DESIGNATED TRUNCATED Complete
2000 R21 PAR-99-100 WEISSMAN, SHERMAN MORTON YALE UNIVERSITY DISPLAY METHODS FOR SURVEYING MUTATIONS Complete
2002 R21 PAR-99-102 MEHTA, ANAND S THOMAS JEFFERSON UNIVERSITY IDENTIFICATION OF SERUM GLYCOSYLATION MARKERS OF HCC Complete
2005 R21 RFA-CA-05-003 LIZARDI, PAUL M. YALE UNIVERSITY GLOBAL DNA METHYLATION PROFILES OF HEAD AND NECK CANCERS Complete
2008 R21 RFA-CA-07-035 KRON, STEPHEN J UNIVERSITY OF CHICAGO MALDI IMAGING OF CANCER SIGNALING SIGNATURES Complete
2011 R21 RFA-CA-10-005 DECAPRIO, ANTHONY P FLORIDA INTERNATIONAL UNIVERSITY PLATFORM FOR HIGH-THROUGHPUT ANALYSIS OF PROTEIN ADDUCTS FOR CARCINOGEN EXPOSURE Complete
2015 R21 RFA-CA-14-005 PENNO, MARGARET B JOHNS HOPKINS UNIVERSITY PEDIATRIC CANCER SALVIA BIOREPOSITORY Complete
1999 R43 PAR-98-066 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD Complete
2001 R43 PAR-99-101 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS WHOLE GENOME METHYLATION ASSAY Complete
2004 R43 PAR-01-105 PARIS, MARK J VACCINEX, INC. FUNCTIONAL IDENTIFICATION OF CANCER REGULATORS Complete
2007 R33 RFA-CA-07-002 MOORE, PATRICK S. UNIVERSITY OF PITTSBURGH AT PITTSBURGH EMERGING TECHNOLOGIES APPLIED TO THE DISCOVERY OF HUMAN TUMOR VIRUSES Complete
2010 R21 RFA-CA-09-008 SOUSA, RUI J. UNIVERSITY OF TEXAS HLTH SCIENCE CENTER DEVELOPMENT OF IMAGING REAGENTS TO MONITOR GTP LEVELS AND GTP/GDP RATIOS IN VIVO Complete
2014 R33 RFA-CA-13-002 FEDERSPIEL, MARK J MAYO CLINIC ROCHESTER VALIDATING TECHNOLOGY TO OPTIMIZE ANTIBODY AFFINITY FOR TARGETING THERAPEUTICS Complete
2001 R33 PAR-98-067 ENGELWARD, BEVIN P. MASSACHUSETTS INSTITUTE OF TECHNOLOGY FLUORESCENCE DETECTION OF GENETIC INSTABILITY IN MICE Complete
2003 R41 PAR-01-105 GUTHOLD, MARTIN NANOMEDICA, INC. NOVEL, SINGLE-MOLECULE APTAMER SELECTION METHOD Complete
2007 R21 RFA-CA-07-001 STEINMAN, RICHARD A UNIVERSITY OF PITTSBURGH AT PITTSBURGH A NUCLEOSOMAL BIOSENSOR FOR IDENTIFICATION AND ISOLATION OF NUCLEAR HORMONE RECEP Complete
2009 R33 RFA-CA-08-008 ELLEDGE, STEPHEN J BRIGHAM AND WOMEN'S HOSPITAL A MULTIPLEX GENOME-WIDE SHRNA SCREENING PLATFORM FOR CANCER-LETHAL GENE DISCOVERY Complete
2013 R33 RFA-CA-12-003 DI CARLO, DINO UNIVERSITY OF CALIFORNIA LOS ANGELES ISOLATING CIRCULATING TUMOR CELLS USING A CENTRIFUGE ON A CHIP Complete
2016 R44 PAR-13-327 KARSTEN, STANISLAV NEUROINDX INC. Automated Platform for Fixed Tissue Microdissection Complete
2000 R43 PAR-98-066 BAMDAD, CYNTHIA C. MINERVA BIOTECHNOLOGIES CORPORATION RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS Complete
2002 R43 PAR-01-105 LOGE, GARY SPECTRUMEDIX CORPORATION AN AUTOMATED 2D-CAPILLARY ELECTROPHORESIS SYSTEM Complete
2006 R21 RFA-CA-06-003 SCHMITTGEN, THOMAS D OHIO STATE UNIVERSITY REAL-TIME PCR EXPRESSION PROFILING OF MICRORNA Complete
2009 R21 RFA-CA-08-006 HELD, JASON M. BUCK INSTITUTE FOR RESEARCH ON AGING OXMRM: A TECHNIQUE TO QUANTIFY OXIDATION OF ENDOGENOUS REDOX-SENSITIVE CYSTEINES Complete

Pages